Table 1 |
|||
|
Clinical central nervous system manifestations in systemic lupus erythematosus patients included in the study |
|||
| CNS manifestations |
NPSLE (n = 43) |
No NPSLE (n = 71) |
aPL syndrome (n = 9) |
|
|
|||
| Acute confusional state |
1 |
1 |
0 |
| Anxiety disorder |
0 |
5 |
0 |
| Aseptic meningitis |
1 |
0 |
0 |
| Cerebrovascular disease |
6 |
8 |
4 |
| Cognitive dysfunction |
9 |
19 |
1 |
| Demyelinating syndrome |
4 |
1 |
0 |
| Headache |
8 |
21 |
4 |
| Mood disorders |
5 |
11 |
1 |
| Movement disorder |
2 |
0 |
3 |
| Myastenia gravis |
0 |
2 |
0 |
| Myelopathy |
1 |
1 |
0 |
| Polyneuropathy |
0 |
1 |
0 |
| Mononeuropathy |
0 |
1 |
0 |
| Neuropathy |
0 |
1 |
0 |
| Psychosis |
7 |
1 |
0 |
| Seizure disorders |
6 |
2 |
0 |
| Tiredness |
0 |
8 |
0 |
|
|
|||
|
Each patient may have had multiple clinical manifestations of central nervous system (CNS) involvement. aPL, antiphospholipid; NPSLE, neuropsychiatric involvement in systemic lupus erythematosus. |
|||
|
Trysberg et al. Arthritis Res Ther 2004 6:R551 doi:10.1186/ar1228 |
|||
